Osteoporosis, bone & mineral

Cardiovascular status in chronic hypoparathyroidism: a systematic cross-sectional assessment in 168 patients

Eur J EndocrinolPublished Cross-sectional study

Authors' conclusion

Patients with hypoPT exhibit a higher prevalence of QTc interval prolongation despite established therapy and an increased incidence of hypertension. Conversely, echocardiography revealed lower left ventricular mass and less frequent left ventricular hypertrophy in hypoPT, but higher prevalence of valve stenosis. Regular monitoring of hypertension, QTc interval prolongation, and valve stenosis is recommended to reduce the risk of cardiovascular diseases.

Study context

Population
Patients with chronic hypoparathyroidism vs matched controls from German population-based cohorts (SHIP-TREND, Stages A-B (STAAB))
Participants
168 hypoparathyroidism (hypoPT) patients
Exposure
Chronic hypoPT vs matched population controls
  • HypoPTn = 168
Outcome
Cardiovascular parameters (BP, ECG, echocardiography)
Methodological details1:3 propensity score matching, matched controls from SHIP-TREND and STAAB cohorts
  • 1:3 propensity score matching
  • Matched controls from SHIP-TREND and STAAB cohorts

Main finding

As reported in the abstract

HypoPT
systolic BP 128 vs 125 mm Hg; P = 0.02
HypoPT
diastolic BP 83 vs 77 mm Hg; P < 0.01
HypoPT
QTc interval 438 vs 420 ms; P < 0.01
HypoPT
QTc interval prolongation 24% vs 6%; P < 0.01
HypoPT
left ventricular mass index 28 vs 43 g/m2.7; P < 0.01
HypoPT
left ventricular hypertrophy 7%% vs 41%; P < 0.01
HypoPT
mitral valve stenosis 20 vs 0%; P < 0.01
HypoPT
aortic valve stenosis 7 vs 2%; P < 0.01
Comparable left ventricular ejection fraction
P = 0.48

Observational data: associations, not effects.

Original publication

Cardiovascular status in chronic hypoparathyroidism: a systematic cross-sectional assessment in 168 patients. Eur J Endocrinol. Published 2 April 2025. doi:10.1093/ejendo/lvaf023

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.